Related Experiment Videos
Echogenic foci in the fetal heart: a marker of chromosomal abnormality
W Sepulveda1, S Cullen, P Nicolaidis
1Centre for Fetal Care, Royal Postgraduate Medical School, Queen Charlotte's and Chelsea Hospital, London, UK.
British Journal of Obstetrics and Gynaecology
|June 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Blood biomarkers to detect functional impairment in adult patients with repaired tetralogy of Fallot.
International journal of cardiology. Congenital heart disease·2024
Outcomes following surgical fixation of Gustilo-Anderson IIIb open tibial fractures.
Acta orthopaedica Belgica·2024
Nail gun injury to the median nerve: A barbed issue.
Trauma case reports·2024
Can Anti-Müllerian Hormone levels predict future pregnancy outcomes in recurrent pregnancy loss?
European journal of obstetrics, gynecology, and reproductive biology·2023
Dual-task gait speed assessments with an electronic walkway and a stopwatch in older adults. A reliability study.
Experimental gerontology·2020
The effect of labour and maternal oxytocin infusion on fetal plasma oxytocin concentration.
British journal of obstetrics and gynaecology·1999
Inconsistencies in classification by experts of cardiotocograms and subsequent clinical decision.
British journal of obstetrics and gynaecology·1999
Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening.
British journal of obstetrics and gynaecology·1999
Serum activin A and inhibin A elevated in pre-eclampsia: no relation to insulin sensitivity.
British journal of obstetrics and gynaecology·1999
Isolated fetal echogenic intracardiac foci or golf balls: is karyotyping for Down's syndrome indicated?
British journal of obstetrics and gynaecology·1999
Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review.
British journal of obstetrics and gynaecology·1999
H3K9me3 inhibition reverses Alzheimer's progression by restoring synaptic and immune proteostasis across the brain-retina axis.
Alzheimer's & dementia : the journal of the Alzheimer's Association·2026